Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes

被引:54
作者
Hoeldtke, RD
Bryner, KD
McNeill, DR
Warehime, SS
Van Dyke, K
Hobbs, G
机构
[1] W Virginia Univ, Dept Med, Sch Med, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA
[2] W Virginia Univ, Dept Biochem & Mol Pharmacol, Morgantown, WV 26506 USA
[3] W Virginia Univ, Dept Community Med & Stat, Morgantown, WV 26506 USA
关键词
D O I
10.1210/jc.2002-021525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to analyze biochemical measures of oxidative stress and assess their relationship to insulin requirements early in type 1 diabetes. Thirty-seven patients enrolled in a 3-yr longitudinal study of the effects of oxidative stress on the early natural history of this disorder. We measured plasma nitrite and nitrate (collectively NOx), nitrotyrosine, and 8-iso-prostaglandin F-2alpha (8-iso-PGF(2alpha)). Plasma NOx was 34.0 +/- 4.9 mumol/liter in the control subjects and 52.4 +/- 5.1, 50.0 +/- 5.1, and 49.0 +/- 5.2 mumol/liter in the diabetic patients at the first, second, and third evaluations, respectively (P < 0.01). Nitrotyrosine was 13.3 +/- 2.0 mu mol/liter in controls and 26.8 +/- 4.4, 26.1 +/- 4.3, and 32.7 +/- 4.3 mu mol/liter in the diabetic patients (P < 0.01). 8-Iso-PGF(2alpha) was higher in the poorly controlled than in the well controlled patients. NOx correlated with insulin dose at the first (P < 0.05), second (P < 0.025), and third (P < 0.05) evaluations. 8-Iso-PGF(2 alpha) correlated with insulin dose at the first (P < 0.01) and third (P < 0.0025) evaluations. Systemic measures of oxidative stress correlate with insulin requirements in early type 1 diabetes. These results suggest that oxidative stress is taking place in the pancreas and damaging the beta-cell.
引用
收藏
页码:1624 / 1628
页数:5
相关论文
共 32 条
[1]  
ALEYASSINE H, 1981, CLIN CHEM, V27, P472
[2]  
Bardell AL, 2001, J PHARMACOL EXP THER, V296, P252
[3]   Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound [J].
Bottino, R ;
Balamurugan, AN ;
Bertera, S ;
Pietropaolo, M ;
Trucco, M ;
Piganelli, JD .
DIABETES, 2002, 51 (08) :2561-2567
[4]   Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria - Relation to glomerular hyperfiltration [J].
Chiarelli, F ;
Cipollone, F ;
Romano, F ;
Tumini, S ;
Costantini, F ;
di Ricco, L ;
Pomilio, M ;
Pierdomenico, SD ;
Marini, M ;
Cuccurullo, F ;
Mezzetti, A .
DIABETES, 2000, 49 (07) :1258-1263
[5]   DOES NITRIC-OXIDE MEDIATE AUTOIMMUNE DESTRUCTION OF BETA-CELLS - POSSIBLE THERAPEUTIC INTERVENTIONS IN IDDM [J].
CORBETT, JA ;
MCDANIEL, ML .
DIABETES, 1992, 41 (08) :897-903
[6]  
COWIE CC, 2001, DIABETES CONTROL COM
[7]  
Davì G, 1999, CIRCULATION, V99, P224
[9]  
Eizirik DL, 1996, DIABETOLOGIA, V39, P875
[10]   Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes [J].
Flodström, M ;
Tyrberg, B ;
Eizirik, DL ;
Sandler, S .
DIABETES, 1999, 48 (04) :706-713